A Novel Ultrafiltrate Extract of Propolis Exerts Anti‐inflammatory Activity through Metabolic Rewiring
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202301315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Yong-Lin Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chinese Medicinal Sciences, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou, 510006,…. Hauptthemen laut MEDLINE: Propolis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Guangdong Natural Science Foundation, Undergraduate Innovation and Entrepreneurship Training Program of Guangdong Pharmaceutical University, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Thousands of years ago, humans started to use propolis because of its medicinal properties, and modern science has successfully identified several bioactive molecules within this resinous bee product. However, a natural propolis extract which has been removed the adhesive glue and preserved propolis bioactive compounds is urgently needed to maximise the therapeutic opportunities. In this study, a novel ultrafiltrate fraction from Brazilian green propolis, termed P30K, was demonstrated with anti‐inflammatory properties, both in vitro and in vivo . Total flavonoids and total phenolic acids content in P30K were 244.6 mg/g and 275.8 mg/g respectively, while the IC 50 value of inhibition of cyclooxygenase‐2 (COX‐2) was 8.30 μg/mL. The anti‐inflammatory activity of P30K was furtherly corroborated in experimental models of lipopolysaccharides (LPS)‐induced acute liver and lung injury. Mechanistically, integrated GC−MS and LC−MS based serum metabolomics analysis revealed that P30K modulated citrate cycle (TCA), pyruvate, glyoxylate and dicarboxylate metabolism pathways to inhibit secretion of pro‐inflammatory cytokines. Results of network pharmacology and molecular docking suggested that P30K targeted catechol‐O‐methyltransferases (COMT), 11β‐hydroxysteroid dehydrogenases (HSD11B1), and monoamine oxidases (MAOA and MAOB) to promote cellular metabolomic rewiring. Collectively, our work reveals P30K as an efficient therapeutic agent against inflammatory conditions and its efficacy is related to metabolic rewiring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chinese Medicinal Sciences, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
- Institute of Chinese Medicinal Sciences, Guangdong Pharmaceutical University, 280 East Road, Outer Ring, Guangzhou Higher Education Mega Center, Guangzhou, China, 510006.
- Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
- BYHEALTH Institute of Nutrition & Health., Guangzhou, 510000, China.
- Centre for the Cellular Microenvironment, University of Glasgow, University Place, Glasgow, G12 8TA, UK.
ORCID-Profile: Kun-Ping Li
Förderung
- Guangdong Natural Science Foundation
- Undergraduate Innovation and Entrepreneurship Training Program of Guangdong Pharmaceutical University
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Wu, Y. L., Zhu, A. Q., Zhou, X. T., Zhang, K. W., Yuan, X. J., Yuan, M., He, J., Pineda, M. A., & Li, K. P. (2024). A Novel Ultrafiltrate Extract of Propolis Exerts Anti‐inflammatory Activity through Metabolic Rewiring. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202301315
Vancouver
Wu YL, Zhu AQ, Zhou XT, Zhang KW, Yuan XJ, Yuan M, et al. A Novel Ultrafiltrate Extract of Propolis Exerts Anti‐inflammatory Activity through Metabolic Rewiring. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202301315
BibTeX
@article{Wu2024,
author = {Wu, Yong-Lin and Zhu, An-Qi and Zhou, Xiao-Ting and Zhang, Ke-Wei and Yuan, Xu-Jiang and Yuan, Min and He, Jian and Pineda, Miguel A and Li, Kun-Ping},
title = {A Novel Ultrafiltrate Extract of Propolis Exerts Anti‐inflammatory Activity through Metabolic Rewiring},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202301315}
}
EUVIMED